Diabetische Kardiomyopathie/Herzinsuffizienz – Neues zu Ursachen, Diagnostik, Therapie

Schlüsselwörter

Kardiomyopathie - Insulinresistenz - Gluko-/Lipotoxizität - Gewebe-Doppler - kardiorenales Syndrom

Keywords

cardiomyopathy - insulin resistance - gluco-/lipotoxocity - tissue Doppler - cardio-renal syndrome

• Literatur

• 1 Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 2014; 57: 660-671
• 2 Chavali V, Tyagi SC, Mishra PK. Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes 2013; 6: 151-160
• 3 Cherian S, Lopaschuk GD, Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Amer J Physiol 2012; 303: E937-949
• 4 Gawlowski T, Stratmann B, Stork I et al. Heat shock protein 27 modification is increased in the human diabetic failing heart. Hormone Metab Res 2009; 41: 594-599
• 5 Koyama S, Sato Y, Tanada Y et al. Early evolution and correlates of urine albumin excretion in patients presenting with acutely decompensated heart failure. Circulation 2013; 6: 227-232
• 6 Marcovina SM, Sirtori C, Peracino A et al. Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of l-carnitine. Translat Res 2013; 161: 73-84
• 7 McMurray JJV, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Europ Heart J 2012; 33: 1787-1847
• 8 Mellor KM, Reichelt ME, Delbridge LM. Autophagy anomalies in the diabetic myocardium. Autophagy 2011; 7: 1263-1267
• 9 Metra M, Cotter G, Gheorghiade M et al. The role of the kidney in heart failure. Europ Heart J 2012; 33: 2135-2142
• 10 Metra M, Ponikowski P, Cotter G et al. Effects of serelaxin in subgroups of patients with acute heart failure: results from relax-ahf. Europ Heart J 2013; 34: 3128-3136
• 11 Riehle CWA, Sena S, Pires KM et al. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J Clin Invest 2013; 123: 5319-5333
• 12 Rijzewijk LJ, Van Der Meer RW, Lamb HJ et al. Effect of pioglitazone versus metformin on myocardial function, metabolism and triglyceride content in men with well-controlled type 2 diabetes mellitus and verified absence of cardiac ischemia in the piramid study (pioglitazone influence on triglyceride accumulation in the myocardium in diabetes). Diabetes 2008; 57: A113-A113
• 13 Ruiz MA, Chakrabarti S. Micro RNAs: The underlying mediators of pathogenetic processes in vascular complications of diabetes. Canad J Diabetes 2013; 37: 339-344
• 14 Stratmann B, Tschoepe D. Heart in diabetes: Not only a macrovascular disease. Diabetes Care 2011; 34 (Suppl. 02) S138-144
• 15 von Bibra H, St John Sutton M. Diastolic dysfunction in diabetes and the metabolic syndrome: Promising potential for diagnosis and prognosis. Diabetologia 2010; 53: 1033-1045
• 16 Weinbrenner S, Langer T, Scherer M et al. Nationale Versorgungsleitlinie Chronische Herzinsuffizienz. Dtsch Med Wochenschr 2012; 137: 219-227
• 17 Halle M, Gitt AK, Hanefeld M et al. Diabetes und Herzinsuffizienz: eine praxisorientierte, kritische Bestandsaufnahme. Dtsch Med Wochenschr 2012; 137: 437-441